Layn Natural Ingredients has announced plans to invest $148 million to expand its infrastructure, as well as drive innovation and R&D in botanical extracts and natural sweeteners.
The China-based company produces stevia and monk fruit natural sweetener extracts; tea extracts; as well as a variety of functional botanical extracts such as pomegranate, rosemary and sophora japonica.
Layn says its planned expansion will help meet the growing global demand of natural sweeteners and polyphenol-rich botanical ingredients.
The company also plans to expand its sustainable agronomy innovation programmes to expand its transparent and traceable supply chain.
Capital will go towards the construction of Layn’s new manufacturing facility, which is expected to be completed in three years and have the capacity to process an additional 4,000 metric tonnes of stevia leaf extract annually.
Meanwhile, the company will put capital towards its innovation centres in Asia, Europe and the US – which conduct ongoing research and provide formulation and lab support to manufacturing partners worldwide.
Layn also plans to use the funding to support its commitment to the discovery of new botanical extract innovations and science for specific botanical compounds.
The investment follows Layn’s acquisition of Chengdu Wagott Bio-tech last year, a Chinese exporter of green tea extract and producer of tea and resveratrol extracts.
© FoodBev Media Ltd 2024